1 | 1 | | 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 SB1413 Introduced 2/6/2023, by Sen. Sue Rezin SYNOPSIS AS INTRODUCED: New Act Creates the Sale of Pharmaceuticals on Social Media Act. Provides that, notwithstanding any other provision of law, no individual shall sell or advertise the sale of a pharmaceutical on social media unless the individual has completed a verification process with specified requirements. LRB103 28324 CPF 54703 b A BILL FOR 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 SB1413 Introduced 2/6/2023, by Sen. Sue Rezin SYNOPSIS AS INTRODUCED: New Act New Act Creates the Sale of Pharmaceuticals on Social Media Act. Provides that, notwithstanding any other provision of law, no individual shall sell or advertise the sale of a pharmaceutical on social media unless the individual has completed a verification process with specified requirements. LRB103 28324 CPF 54703 b LRB103 28324 CPF 54703 b A BILL FOR |
---|
2 | 2 | | 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 SB1413 Introduced 2/6/2023, by Sen. Sue Rezin SYNOPSIS AS INTRODUCED: |
---|
3 | 3 | | New Act New Act |
---|
4 | 4 | | New Act |
---|
5 | 5 | | Creates the Sale of Pharmaceuticals on Social Media Act. Provides that, notwithstanding any other provision of law, no individual shall sell or advertise the sale of a pharmaceutical on social media unless the individual has completed a verification process with specified requirements. |
---|
6 | 6 | | LRB103 28324 CPF 54703 b LRB103 28324 CPF 54703 b |
---|
7 | 7 | | LRB103 28324 CPF 54703 b |
---|
8 | 8 | | A BILL FOR |
---|
9 | 9 | | SB1413LRB103 28324 CPF 54703 b SB1413 LRB103 28324 CPF 54703 b |
---|
10 | 10 | | SB1413 LRB103 28324 CPF 54703 b |
---|
11 | 11 | | 1 AN ACT concerning regulation. |
---|
12 | 12 | | 2 Be it enacted by the People of the State of Illinois, |
---|
13 | 13 | | 3 represented in the General Assembly: |
---|
14 | 14 | | 4 Section 1. Short title. This Act may be cited as the Sale |
---|
15 | 15 | | 5 of Pharmaceuticals on Social Media Act. |
---|
16 | 16 | | 6 Section 5. Definition. In this Act, "social media" has the |
---|
17 | 17 | | 7 same meaning as defined in Section 6-5 of the Liquor Control |
---|
18 | 18 | | 8 Act of 1934. |
---|
19 | 19 | | 9 Section 10. Sale of pharmaceuticals on social media; |
---|
20 | 20 | | 10 verification process. Notwithstanding any other provision of |
---|
21 | 21 | | 11 law, no individual shall sell or advertise the sale of a |
---|
22 | 22 | | 12 pharmaceutical on social media unless the individual has |
---|
23 | 23 | | 13 completed the following verification process: |
---|
24 | 24 | | 14 (1) the individual shall submit an image of both the |
---|
25 | 25 | | 15 front and back of the individual's state-issued |
---|
26 | 26 | | 16 identification card to the social media platform upon or |
---|
27 | 27 | | 17 through which the pharmaceutical is to be sold or |
---|
28 | 28 | | 18 advertised; |
---|
29 | 29 | | 19 (2) a disclaimer must be included in any advertisement |
---|
30 | 30 | | 20 for the pharmaceutical on the social media platform that |
---|
31 | 31 | | 21 clearly discloses the name of the individual selling the |
---|
32 | 32 | | 22 pharmaceutical; |
---|
33 | 33 | | |
---|
34 | 34 | | |
---|
35 | 35 | | |
---|
36 | 36 | | 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 SB1413 Introduced 2/6/2023, by Sen. Sue Rezin SYNOPSIS AS INTRODUCED: |
---|
37 | 37 | | New Act New Act |
---|
38 | 38 | | New Act |
---|
39 | 39 | | Creates the Sale of Pharmaceuticals on Social Media Act. Provides that, notwithstanding any other provision of law, no individual shall sell or advertise the sale of a pharmaceutical on social media unless the individual has completed a verification process with specified requirements. |
---|
40 | 40 | | LRB103 28324 CPF 54703 b LRB103 28324 CPF 54703 b |
---|
41 | 41 | | LRB103 28324 CPF 54703 b |
---|
42 | 42 | | A BILL FOR |
---|
43 | 43 | | |
---|
44 | 44 | | |
---|
45 | 45 | | |
---|
46 | 46 | | |
---|
47 | 47 | | |
---|
48 | 48 | | New Act |
---|
49 | 49 | | |
---|
50 | 50 | | |
---|
51 | 51 | | |
---|
52 | 52 | | LRB103 28324 CPF 54703 b |
---|
53 | 53 | | |
---|
54 | 54 | | |
---|
55 | 55 | | |
---|
56 | 56 | | |
---|
57 | 57 | | |
---|
58 | 58 | | |
---|
59 | 59 | | |
---|
60 | 60 | | |
---|
61 | 61 | | |
---|
62 | 62 | | SB1413 LRB103 28324 CPF 54703 b |
---|
63 | 63 | | |
---|
64 | 64 | | |
---|
65 | 65 | | SB1413- 2 -LRB103 28324 CPF 54703 b SB1413 - 2 - LRB103 28324 CPF 54703 b |
---|
66 | 66 | | SB1413 - 2 - LRB103 28324 CPF 54703 b |
---|
67 | 67 | | 1 (3) the individual must be identified on the social |
---|
68 | 68 | | 2 media page upon which the pharmaceutical is being sold or |
---|
69 | 69 | | 3 advertised; and |
---|
70 | 70 | | 4 (4) the individual must display a disclaimer on the |
---|
71 | 71 | | 5 individual's main page on the social media platform |
---|
72 | 72 | | 6 stating that the owner or operator sells or advertises the |
---|
73 | 73 | | 7 pharmaceutical on that social media platform. |
---|
74 | 74 | | |
---|
75 | 75 | | |
---|
76 | 76 | | |
---|
77 | 77 | | |
---|
78 | 78 | | |
---|
79 | 79 | | SB1413 - 2 - LRB103 28324 CPF 54703 b |
---|